HIV

ViiV Healthcare announces US FDA approval of the first-ever dispersible tablet formulation of dolutegravir, Tivicay PD, a once-daily treatment for children living with HIV

By
1 Mins read
110
0
Share
Reading Time: < 1 minute

ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders Read More

110
0
Share
Related posts
HIV

US shutdown of HIV/Aids funding ‘could lead to 500,000 deaths in South Africa’

By
1 Mins read
Reading Time: < 1 minute Sweeping notices of termination of funding have been received by organisations working with HIV and Aids across Africa, with dire predictions of…
HIV

'HIV in soda' hoax scares Philippine social media users

By
1 Mins read
Reading Time: < 1 minute HIV cannot be transmitted through drinking “contaminated” soda, health experts said, refuting hoax posts that frightened social media users in the Philippines. …
HIV

South African NGOs worry Trump's aid freeze will cause HIV patients to default on treatment

By
1 Mins read
Reading Time: < 1 minute At a rural village in South Africa’s KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for…
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.